Get started
Boston Scientific CorporationBoston Scientific CorporationBoston Scientific Corporation

Boston Scientific Corporation

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

BSX trade ideas

Morning Overview: Pullback and Anti Pattern's To Trade TodayThis morning I covered the overview of AMEX:SPY $AMEX:DIA. I talked about pattern recognition across markets, I gave valuable insight into potential pullbacks and anti patterns that are setting up. I provide entry ideas and mentioned the stocks that I like for trading today. Many of which were short today. I think that coming into the day the market is offer many short patterns and rightfully so after yesterday's massive bear bar.
NYSE:BSX
by JoeRodTrades
Confirmed cup and handle pattern on BSX chartHi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is easily possible, that we will become a news, that a company will cooperate with BSX, to integrate his technology in the robots. So an infomration could indicate a price action, that could push the price to the tartget, or above them. BUT, that all is just spculation. Please take care, that this is absolutely my opinion, and not an financial advise. In every chase take your research, and analyse. Be careful and good luck! BR, T
NYSE:BSXLong
by Thomasson1212
2
🏥💼 Boston Scientific (BSX) Investment Analysis 💡📈Strategic Acquisitions: Boston Scientific's recent acquisitions, including Axonics, Relievant Medsystems, and partial offer for Acotec, signify its proactive expansion strategy, targeting new growth opportunities in medical segments and lucrative markets like China. Innovative Product Introductions: Introduction of innovative products strengthens Boston Scientific's industry position and demonstrates commitment to addressing unmet medical needs. Investment Outlook: Bullish sentiment on NYSE:BSX , fueled by strategic initiatives and potential for revenue growth. Upside target of $86.00-$88.00 reflects optimistic expectations for Boston Scientific's execution of growth strategies and capitalization on recent acquisitions and product launches. 📊🚀 Stay tuned for BSX's growth trajectory! #BostonScientific #InvestmentAnalysis 📈💼
NYSE:BSXLong
by Richtv_official
BSX - Short IdeaI believe BSX had a good run up the past couple of weeks. And by looking at how its finding resistance at the top key levels, I expect to have a potential move down to $54 area. Again, risk management is key. Expected return vs risk is important. Always keep that in mind. The markets are choppy so you got to be careful on your entires. Ill give it til beginning of next month to hit target if it does. And if it doesnt, its all good. Risk to Reward is 1:3. Best of luck! #options
NYSE:BSXShort
by EBGtrader
$BSX Soars to Record Highs: A Compelling Investment Opportunity With a recent surge to record highs, fueled by positive developments and robust financial performance, here's a compelling case for potential buyers to consider adding NYSE:BSX stock to their portfolios. 1. Technical Analysis: Riding the Rising Trend Channel Boston Scientific is currently riding a rising trend channel in the medium to long term, reflecting increasing optimism among investors. The stock has recently broken a rectangle formation, further indicating a strong bullish sentiment. The absence of resistance in the price chart suggests the potential for continued upward momentum. A decisive break of the resistance at $56.91 is anticipated to trigger a further rise to $58.50 or more. 2. Strategic Gap-Up and Buy Zone Expansion The recent gap-up in Boston Scientific's stock price on heavy volume, coupled with bypassing a key alternative buy point at $56.90, underscores strong positive momentum. Investors should take note that shares are currently within a 5% buy zone, extending up to $59.75. This presents an attractive entry point for those looking to capitalize on the stock's upward trajectory. 3. FARAPULSE Treatment Anticipation Boosts Confidence Boston Scientific's recent announcement regarding the anticipated FDA approval of its FARAPULSE treatment for a heart condition in the first quarter of 2024 has significantly boosted investor confidence. This development not only signals the company's commitment to innovation but also opens up new revenue streams, potentially driving the stock price higher. 4. Impressive Year-to-Date Performance With a remarkable 24% gain in the current year, Boston Scientific has consistently outperformed market expectations. The stock touched a record high on a recent Friday, showcasing the market's positive response to the company's strategic initiatives and strong financial performance. 6. Upgraded 2023 Earnings Outlook Notably, Boston Scientific raised its full-year 2023 earnings outlook in its latest report, reflecting management's confidence in sustained growth. Such positive guidance provides investors with a clear signal of the company's strong fundamentals and future potential. As Boston Scientific continues its upward trajectory, propelled by a confluence of positive technical indicators, strategic developments, and robust financial performance, now may be an opportune moment for investors to consider adding NYSE:BSX stock to their portfolios. The anticipation of FDA approval for FARAPULSE, coupled with the company's impressive year-to-date gains, positions Boston Scientific as a compelling investment opportunity with the potential for continued growth in the foreseeable future. As always, investors are encouraged to conduct thorough research and consult with financial advisors before making any investment decisions.
NYSE:BSX
by DEXWireNews
BSX Entry, Volume, Target, StopEntry: when price clears 54.17 Volume: with daily volume greater than 7M Target: 58 area Stop: Depending on your risk tolerance; 52.91 gets you 3/1 Risk/Reward. This swing trade idea is not trade advice and is strictly based on my ideas and technical analysis. No due diligence or fundamental analysis was performed while evaluating this trade idea. Do not take this trade based on my idea, do not follow anyone blindly, do your own analysis and due diligence. I am not a professional trader.
NYSE:BSXLong
by tradepatiently
Boston Scientific Fundamental Strength and Technical BreakoutBoston Scientific develops, manufactures, and markets medical devices. Q4 earnings were reported this week providing a clear picture of 2022 annual fundamentals. The fundamentals considered are presented on the chart with brief commentary. Technical considerations: Price bounced off of trend line going back to 2012 Ascending triangle breakout New ATH weekly close Positions: Entry: 100 shares @ $48.71 Target: $67.43 by July 2025 Stop: $44.19 (~20-week SMA, below 2023 low) R/R: 4.14 Reward: $1872 Risk: $452 Time Horizon: 12+ months Current price (weekly close): $48.50 Risk Analysis Chart: Main chart before distorted by publishing process:
NYSE:BSXLong
by Skipper86
BSX 6% short puts. then New ATH buying callsHey Everyone, The market has been doing so crazy things the last year. Here is a company that seems to be handling market turmoil well. BSX has recently retraced from the ATH of 47ish @ share. My personal view of BSX in the next couple of months are the following. in the next 2 weeks I anticipate that BSX will retrace to the 43 @ share level. I judge this off the fact that MACD has just crossed on the daily. Especially after reaching an ATH. The 43 level is the .618 retracement level, as well as the 50day moving average (roughly). RSI has also been on the overbought level for the majority of the fourth quarter. I think They will be affected by 1st quarter earnings as many companies will with rates and everything else consumer and so forth.. But I think once that's priced in, it's off to 50. BSX has also been going up since late Sept and unless the trend gets broken, I believe it will continue to go up and level out at around the 50-55 range. 43 seems to be really strong support so at the very least it will trade sideways while the rest of the market tanks.
NYSE:BSXLong
by ATX2014